Gentiopicroside ameliorates bleomycin-induced pulmonary fibrosis in mice via inhibiting inflammatory and fibrotic process-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gentiopicroside ameliorates bleomycin-induced pulmonary fibrosis in mice via inhibiting inflammatory and fibrotic process

Published:2018-01 Issue:4 Volume:495 Page:2396-2403
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Chen Cheng,Wang Yong-yan,Wang Ying-xia,Cheng Meng-qun,Yin Jian-bing,Zhang Xuan,Hong Zhi-peng

Funder

National Natural Science Foundation of China

Training Program for Young and Middle-aged Academic and Technical Leaders of Yunnan Province

Applied Basic Research Programs of Science and Technology Department of Yunnan Province

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference30 articles.

1. Idiopathic pulmonary fibrosis: recent advances on pharmacological therapy;Spagnolo;Pharmacol Ther,2015

2. Pirfenidone: a review of its use in idiopathic pulmonary fibrosis;Kim;Drugs,2015

3. Nintedanib in the treatment of idiopathic pulmonary fibrosis;Mazzei;Ther. Adv. Respir. Dis.,2015

4. The safety and tolerability of ninteddnib in the treatment of idiopathic pulmonary fibrosis;Cottin;Expet Opin. Drug Saf.,2017

5. Role of pirfenidone in the management of pulmonary fibrosis;Meyer;Ther Clin Risk Manag,2017

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geniposide ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β/Smad and p38MAPK signaling pathways;PLOS ONE;2024-09-06

2. Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways;Biomedicine & Pharmacotherapy;2024-08

3. Hot Spots of Bitter Compounds in the Roots of Gentiana lutea L. subsp. aurantiaca: Wild and Cultivated Comparative;Agronomy;2024-05-17

4. Drugs targeting CTGF in the treatment of pulmonary fibrosis;Journal of Cellular and Molecular Medicine;2024-05

5. Traditional Tibetan medicine: therapeutic potential in lung diseases;Frontiers in Pharmacology;2024-03-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3